Thursday
SESSION 14: WHAT’S NEW IN EMBOLIZATION OF BENIGN AND MALIGNANT DISEASE - PART 1
SESSION 14 SCHEDULE
10:00 AM - 10:10 AM Evaluation And Management Of Prostatic Hypertrophy
  Presenter(s):Lloyd S. Minsky, MD  
10:10 AM - 10:20 AM Prostatic Embolization For BPH: Is It Ready For Prime Time?
  Presenter(s):Tiago Bilhim, MD, PhD, EBIR  
  View Abstract      
10:20 AM - 10:30 AM Single Center Results For BPH Embolization: Is It Worth The Risks?
  Presenter(s):Francisco C. Carnevale, MD, PhD  
10:30 AM - 10:40 AM Prostate Embolization: Technical Tips Based On Our Early Experience
  Presenter(s):Jafar Golzarian, MD  
10:40 AM - 10:50 AM UFE: Are There Any True Contraindications?
  Presenter(s):David N. Siegel, MD  
10:50 AM - 11:00 AM Managing Complications Of UFE
  Presenter(s):Richard D. Shlansky-Goldberg, MD  
11:00 AM - 11:10 AM CO2 Angiography Can Significantly Decrease Contrast Use In The IR Suite
  Presenter(s):James Caridi, MD  
11:10 AM - 11:20 AM Preplanning IR Procedures Will Reduce Radiation Exposure To Both Patients And Operators
  Presenter(s):Gabriel Bartal, MD, FSIR, FCIRSE  
  View Abstract      
11:20 AM - 11:30 AM Managing Patients With HCC: What The Interventional Radiologist Needs To Know
  Presenter(s):Paul J. Gaglio, MD  
  View Abstract      
11:30 AM - 11:40 AM TACE Or Ablation: Which Is Best Or Is There A Role For Both?
  Presenter(s):Daniel B. Brown, MD  
11:40 AM - 11:50 PM DEB TACE Has Surpassed Conventional TACE: Where Is The Evidence?
  Presenter(s):Jean Francois H. Geschwind, MD  
11:50 AM - 12:00 PM Radioembolization (Y90) For The Treatment Of HCC
  Presenter(s):Matthew S. Johnson, MD  
  View Abstract      
12:00 PM - 12:50 PM Lunch Break (Americas Hall I – 3rd Floor)
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 14
previous next